[1] Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys

[2] The evolving role of inflammation in obesity and the metabolic syndrome

[3] Blunted fasting-induced hypothalamic activation and refeeding hyperphagia in late-onset obesity